On October 9, 2020, the existing director and officer of the Company resigned effective immediately. Accordingly, Sukhmanjit Singh, serving as a director and an officer, ceased to be the Company’s Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director. At the effective date of the resignation, Mr. Terry Wilshire consented to act as the new President and Member of the Board of Directors of the Company and Robert Dickenson consented to act as the new Vice President and Member of the Board of Directors of the Company.
On March 4, 2021, Mikrocoze, Inc. filed a Certificate of Amendment with the Secretary of State of Nevada effecting a name change on March 11, 2021 to Instadose Pharma Corp. Further on March 11, 2021, the Financial Industry Regulatory Authority approved the name change and trading symbol to “INSD”. Instadose Pharma Corp. is now focused on growth and acquisition of pharmaceutical grade agricultural products.
Item 1.01 Entry into a Material Definitive Agreement.
Final Court Order
On October 19, 2021, Instadose Pharma Corp (“Instadose Canada” or the “Petitioner”) applied to the Supreme Court of British Columbia (the “Court”) in connection with a proposed plan of arrangement (the “Plan of Arrangement”) giving effect to an arrangement (the “Arrangement”) under section 288 of the Business Corporations Act (British Columbia), S.B.C. 2002, c.57, as amended, (the “BCBCA”) involving the Petitioner, its shareholders and Instadose Pharma Corp. (formerly Mikrocoze Inc.) (“MZKR”).
News 
Market Data 
Discover 
